Longevity science has shifted from theory to commercial reality. With breakthroughs in aging biology, AI-driven drug development, and new regulatory pathways, pharma can now target the root mechanisms of aging. This blog reveals why aging is finally druggable, and how Anervea accelerates this new era of therapeutics.